# Darmiyan: Health, San Francisco, United States

> Darmiyan: Darmiyan is a healthcare technology company focused on the early detection and diagnosis of neurodegenerative diseases, particularly Alzheimer's...

Source: https://millionrounds.com/startup/darmiyan (Millionrounds; every figure on the page links to its filing or article)

United States · [Health startup](https://millionrounds.com/companies)

# Darmiyan

Darmiyan is a healthcare technology company focused on the early detection and diagnosis of neurodegenerative diseases, particularly Alzheimer's disease and dementia.

Funding reported Last round: Undisclosed round

Health San Francisco, United States

Company summary

- **Founded:** 2016 10 years old
- **Team:** 23 11 to 50 people
- **Funding reported:** $15M in dollars
- **Last round:** Undisclosed round Oct 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Darmiyan has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Darmiyan

Darmiyan is a healthcare technology company focused on the early detection and diagnosis of neurodegenerative diseases, particularly Alzheimer's disease and dementia.

Founded in 2014 and based in San Francisco, California, with an office in Toronto, Canada, Darmiyan aims to illuminate brain health long before clinical signs of memory loss appear. The company is led by Padideh Kamali-Zare, PhD, and has received significant funding from industry leaders, along with patents for its innovative technology, BrainSee. BrainSee is the first FDA-approved medical software designed to assist physicians in evaluating the prognosis of patients with amnestic mild cognitive impairment (aMCI). It integrates standard clinical brain MRIs with cognitive test scores to provide a prognostic score that helps predict the likelihood of progression to Alzheimer's dementia. Darmiyan's technology is non-invasive and utilizes advanced AI for high accuracy in detecting abnormalities at a cellular level. The company also offers services for clinical prognostication, clinical trial support, and patient monitoring, aiming to improve outcomes in the field of neurology.

## What company datasets say Darmiyan raised

Funding, as reported

Reported in all **$15M** in dollars

Rounds **6**

Last round **Undisclosed round**

Last round size **$3.5M**

Last round date **Oct 2023**

Investors listed **18**

SEC Form D **$10.0M sold, 2 filings, last Oct 2023**

Y Combinator **S17**

## Founders and team

From Darmiyan's own website and the SEC filings it signed: 3 on the team.

- **Lead Developer** Head of Innovations
- **Financial Advisor** Medical Director of Neuroradiology at RadNet
- **Padideh Kamali-Zare** Executive Officer i

On the board, as filed i *Kaveh Vejdani* *Takehiro Shirai*

Advisers *Ahmad Anvari* *Ilyse Veron* *Larry Atkins*

## On 3 portfolio pages

Investors who name them

- [UpHonest Capital](https://millionrounds.com/fund/uphonest-capital)
- [AAF Management Ltd.](https://millionrounds.com/fund/aaf-management-ltd)
- [Eisai Innovation](https://millionrounds.com/fund/eisai-innovation)

Each firm lists Darmiyan on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care brain health monitoring therapeutic evaluation cloud data science medical ai validation enterprises brain health assessment early diagnosis of alzheimer's brain disease progression prediction monitoring information technology & services early alzheimer's diagnosis enterprise software information technology predictive analytics for dementia

Built with from their website

Contact Form 7 WordPress.org HREF Lang Font Awesome Elementor Google Workspace Viewport Meta Google Meet Priority Hints imagesLoaded

+8 more

MySQL PrimeNG Mobile Friendly Multilingual Open Graph Elementor Header & Footer Builder jQuery Swiper

- **Sector:** Health
- **Industry code:** NAICS 33911, 51321, SIC 3822, 3841, 7372
- **Region:** California
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/darmiyan)

## Health in United States

Startups like it

- [**Judi Health** New York *Raised*](https://millionrounds.com/company/judi-health)
- [**PatientsLikeMe** Boston · founded 2004 *Raised*](https://millionrounds.com/company/patientslikeme)
- [**Aescape** New York · founded 2017 *Raised*](https://millionrounds.com/company/aescape)
- [**Noom** New York · founded 2008 *Raised*](https://millionrounds.com/company/noom)
- [**Healthee** New York · founded 2021 *Raised*](https://millionrounds.com/company/healthee)
- [**Viome** Bellevue · founded 2016 *Raised*](https://millionrounds.com/company/viome)
- [**Tonal** San Francisco · founded 2015 *Raised*](https://millionrounds.com/company/tonal)
- [**Gaia Herbs** Brevard · founded 1987 *Raised*](https://millionrounds.com/company/gaia-herbs)

## Is this your company?

Add your raise, your deck and your story, and put Darmiyan in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)